XML 89 R75.htm IDEA: XBRL DOCUMENT v3.25.1
Schedule of Financial Data for the Company’s Reportable Segment (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]    
Research and development expenses $ 3,378 $ 90
General and administrative expenses 12,041 5,172
Loss from segment operations (15,419) (5,262)
Operating Segments [Member]    
Segment Reporting Information [Line Items]    
General and administrative expenses – other 4,060 1,073
Loss from segment operations 15,419 5,262
Operating Segments [Member] | New Licenses [Member]    
Segment Reporting Information [Line Items]    
Research and development expenses 3,114
Operating Segments [Member] | Clinical Asset Development [Member]    
Segment Reporting Information [Line Items]    
Research and development expenses 264 90
Operating Segments [Member] | Legal And Professional Fees [Member]    
Segment Reporting Information [Line Items]    
General and administrative expenses 2,258 314
Operating Segments [Member] | Accounting And Audit Fees [Member]    
Segment Reporting Information [Line Items]    
General and administrative expenses 1,625 3,064
Operating Segments [Member] | Salaries Payroll And Stock Based Compensation [Member]    
Segment Reporting Information [Line Items]    
General and administrative expenses $ 4,098 $ 721